Papers - YONEYAMA Tohru
-
Effect of active anticancer therapy on serologic response to SARS-CoV-2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma.
Kyo Togashi, Shingo Hatakeyama, Tohru Yoneyama, Tomoko Hamaya, Takuma Narita, Naoki Fujita, Hiromichi Iwamura, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 29 ( 7 ) 733 - 739 2022.3
-
Effect of advanced glycation end products on nocturia or sleep disorders: A longitudinal study.
Konishi S, Hatakeyama S, Imai A, Okita K, Kido K, Ozaki Y, Uemura N, Iwane T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
BJUI compass 3 ( 2 ) 162 - 168 2022.3
-
The impact of eligibility for maintenance immunotherapy on prognosis in patients with unresectable or metastatic urothelial carcinoma.
Ozaki K, Hatakeyama S, Tanaka T, Noro D, Tokui N, Horiguchi H, Okuyama Y, Fujita N, Okamoto T, Okamoto A, Suzuki Y, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
BJUI compass 3 ( 2 ) 139 - 145 2022.3
-
Prognostication in Japanese patients with bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer undergoing early radical cystectomy.
Nishimura N, Miyake M, Iida K, Miyamoto T, Tomida R, Numakura K, Inokuchi J, Yoneyama T, Matsumura Y, Yajima S, Masuda H, Terada N, Taoka R, Kobayashi T, Kojima T, Matsui Y, Nishiyama N, Kitamura H, Nishiyama H, Fujimoto K
International journal of urology : official journal of the Japanese Urological Association 29 ( 3 ) 242 - 249 2022.3
-
Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma.
Okuyama Y, Hatakeyama S, Numakura K, Narita T, Tanaka T, Miura Y, Sasaki D, Noro D, Tokui N, Okamoto T, Yamamoto H, Narita S, Yoneyama T, Hashimoto Y, Habuchi T, Ohyama C
BJUI compass 3 ( 2 ) 154 - 161 2022.3
-
Prognostic impact of eligibility for adjuvant immunotherapy in locally advanced urothelial cancer.
Miura Y, Hatakeyama S, Tanaka T, Fujita N, Horiguchi H, Okuyama Y, Kojima Y, Noro D, Tokui N, Okamoto T, Yamamoto H, Ito H, Yoneyama T, Hashimoto Y, Ohyama C
BJUI compass 3 ( 2 ) 146 - 153 2022.3
-
Effects of six-cycle completion and earlier use of radium-223 therapy on prognosis for metastatic castration-resistant prostate cancer: A real-world multicenter retrospective study.
Sasaki D, Hatakeyama S, Kawaguchi H, Hatayama Y, Ishibashi Y, Kusaka A, Noro D, Tanaka T, Ito H, Okuyama Y, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Aoki M, Ohyama C
Urologic oncology 40 ( 2 ) 64.e1 - 64.e8 2022.2
-
イムノグロブリンN-glycan signatureによる尿路上皮癌の診断法
小玉 寛健, 米山 徹, 田中 壽和, 野呂 大輔, 飛澤 悠葵, 山本 勇人, 須藤 晋一郎, 畠山 真吾, 米山 高弘, 橋本 安弘, 柿崎 育子, 中路 重之, 大山 力
日本泌尿器科学会総会 109回 AOP07 - 01 2021.12
-
フレイルと合併症は限局性前立腺癌の治療選択に関与する因子である
小玉 寛健, 畠山 真吾, 岡本 哲平, 米山 徹, 山本 勇人, 米山 高弘, 橋本 安弘, 大山 力
日本泌尿器科学会総会 109回 PP33 - 04 2021.12
-
Simultaneous analysis of serum a 2,3-linked sialylation and core-type fucosylation of PSA for the detection of clinically significant prostate cancer(和訳中)
波多野 浩士, 米山 徹, 畠山 真吾, 藤田 和利, 三善 英知, 吉村 一宏, 植村 天受, 大山 力, 野々村 祝夫
日本泌尿器科学会総会 109回 ISP02 - 03 2021.12
-
Simultaneous analysis of serum α2,3-linked sialylation and core-type fucosylation of prostate-specific antigen for the detection of high-grade prostate cancer.
Koji Hatano, Tohru Yoneyama, Shingo Hatakeyama, Eisuke Tomiyama, Mutsumi Tsuchiya, Mitsuhisa Nishimoto, Kazuhiro Yoshimura, Eiji Miyoshi, Hirotsugu Uemura, Chikara Ohyama, Norio Nonomura, Kazutoshi Fujita
British journal of cancer 126 ( 5 ) 764 - 770 2021.11
-
Utility of total cell-free DNA levels for surgical damage evaluation in patients with urological surgeries.
Sakae Konishi, Takuma Narita, Shingo Hatakeyama, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Yuki Tobisawa, Daisuke Noro, Tendo Sato, Kyo Togashi, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Scientific reports 11 ( 1 ) 22103 - 22103 2021.11
-
血清イムノグロブリンN-glycan signatureによる尿路上皮癌の診断法
小玉 寛健, 米山 徹, 田中 壽和, 野呂 大輔, 須藤 晋一郎, 飛澤 悠葵, 山本 勇人, 畠山 真吾, 米山 高弘, 橋本 安弘, 柿崎 育子, 中路 重之, 大山 力
日本癌治療学会学術集会抄録集 59回 O18 - 3 2021.10
-
高リスク上部尿路上皮癌への術前化学療法と腫瘍学的転帰の傾向 多施設後ろ向き研究
濱谷 智子, 畠山 真吾, 田中 壽和, 久保田 優花, 富樫 赳, 細越 正吾, 藤田 尚紀, 日下 歩, 得居 範子, 岡本 哲平, 山本 勇人, 米山 徹, 米山 高弘, 橋本 安弘, 大山 力
日本癌治療学会学術集会抄録集 59回 O22 - 1 2021.10
-
Characteristics of α2,3-sialyl N-glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level.
Tohru Yoneyama, Hayato Yamamoto, Mihoko Sutoh Yoneyama, Yuki Tobisawa, Shingo Hatakeyama, Takuma Narita, Hirotake Kodama, Masaki Momota, Hiroyuki Ito, Shintaro Narita, Fumiyasu Tsushima, Koji Mitsuzuka, Takahiro Yoneyama, Yasuhiro Hashimoto, Wilhelmina Duivenvoorden, Jehonathan H Pinthus, Shingo Kakeda, Akihiro Ito, Norihiko Tsuchiya, Tomonori Habuchi, Chikara Ohyama
The Prostate 81 ( 16 ) 1411 - 1427 2021.9
-
Comparison of pembrolizumab with conventional chemotherapy after first-line platinum-based chemotherapy for advanced urothelial carcinoma in real-world practice: A multicenter retrospective study.
Takuma Narita, Shingo Hatakeyama, Kazuyuki Numakura, Mizuki Kobayashi, Yumina Muto, Mitsuru Saito, Shintaro Narita, Toshikazu Tanaka, Daisuke Noro, Noriko Tokui, Takahiro Yoneyama, Yasuhiro Hashimoto, Tomonori Habuchi, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 28 ( 9 ) 899 - 905 2021.9
-
腎臓結石形成に関与する糖鎖変異オステオポンチンの同定
阿南 剛, 米山 徹, 畠山 真吾, 米山 高弘, 橋本 安弘, 佐藤 信, 大山 力
日本腎臓学会誌 63 ( 4 ) 447 - 447 2021.6
-
The effect of number of treatment cycles of platinum-based first-line chemotherapy on maximum radiological response in patients with advanced urothelial carcinoma.
Kazutaka Okita, Shingo Hatakeyama, Kazuhisa Hagiwara, Yuichiro Suzuki, Toshikazu Tanaka, Daisuke Noro, Noriko Tokui, Naoki Fujita, Sakae Konishi, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Urologic oncology 39 ( 12 ) 832.e17 - 832.e23 2021.4
-
Narrative review of urinary glycan biomarkers in prostate cancer.
Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Hayato Yamamoto, Chikara Ohyama
Translational andrology and urology 10 ( 4 ) 1850 - 1864 2021.4
-
Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer.
Hirotaka Horiguchi, Shingo Hatakeyama, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Toshikazu Tanaka, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Tadashi Yoshizawa, Yasuhiro Hashimoto, Toshiaki Kawaguchi, Chikara Ohyama
Urologic oncology 39 ( 4 ) 238.e9-238.e17 - 238.e17 2021.4